These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3079838)

  • 1. Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activator.
    Graor RA; Risius B; Young JR; Denny K; Beven EG; Geisinger MA; Hertzer NR; Krajewski LP; Lucas FV; O'Hara PJ
    J Vasc Surg; 1986 Jan; 3(1):115-24. PubMed ID: 3079838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts.
    Risius B; Graor RA; Geisinger MA; Zelch MG; Lucas FV; Young JR; Grossbard EB
    Radiology; 1986 Jul; 160(1):183-8. PubMed ID: 3086930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
    Graor RA; Risius B; Lucas FV; Young JR; Ruschhaupt WF; Beven EG; Grossbard EB
    Circulation; 1986 Sep; 74(3 Pt 2):I15-20. PubMed ID: 3091288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: preliminary report.
    Krupski WC; Feldman RK; Rapp JH
    J Vasc Surg; 1989 Nov; 10(5):491-8; discussion 499-500. PubMed ID: 2509737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses.
    Risius B; Graor RA; Geisinger MA; Zelch MG; Lucas FV; Young JR
    Radiology; 1987 Aug; 164(2):465-8. PubMed ID: 3110860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term results after intra-arterial thrombolysis of occluded lower extremity bypass grafts using recombinant tissue plasminogen activator for acute limb-threatening ischemia.
    Khosla S; Jain P; Manda R; Razminia M; Guerrero M; Trivedi A; Vidyarthi V; Elbazour M; Kunjummen B; Ahmed A; Lubell D
    Am J Ther; 2003; 10(1):3-6. PubMed ID: 12522513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tissue plasminogen activator and urokinase in a canine model of prosthetic graft thrombosis.
    Curl GR; Jakubowski JA; Nabseth DC; Bush HL
    Arch Surg; 1986 Jul; 121(7):782-8. PubMed ID: 3087327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique.
    Ward AS; Andaz SK; Bygrave S
    J Vasc Surg; 1994 Mar; 19(3):503-8. PubMed ID: 8126864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intra-arterial thrombolysis using rt-PA for the treatment of occluded infra-inguinal bypasses].
    Magnan PE; Moulin G; Chagnaud C; Rosset E; Bartoli JM; Branchereau A
    J Mal Vasc; 1994; 19(2):119-25. PubMed ID: 8077860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modified manual rt-PA pulse-spray lysis in occlusions of leg arteries and femoro-popliteal bypasses].
    Müller-Hülsbeck S; Schwarzenberg H; Link J; Walluscheck K; Brossmann J; Regensburger D; Heller M
    Rofo; 1996 Dec; 165(6):557-62. PubMed ID: 9026098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary report.
    Graor RA; Risius B; Young JR; Lucas FV; Beven EG; Hertzer NR; Krajewski LP; O'Hara PJ; Olin J; Ruschhaupt WF
    J Vasc Surg; 1988 Feb; 7(2):347-55. PubMed ID: 3123719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of thrombolysis in infrainguinal bypass grafts.
    Sullivan KL; Gardiner GA; Kandarpa K; Bonn J; Shapiro MJ; Carabasi RA; Smullens S; Levin DC
    Circulation; 1991 Feb; 83(2 Suppl):I99-105. PubMed ID: 1991406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
    Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
    Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
    Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
    Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator in peripheral arterial thrombolysis.
    Berridge DC; Gregson RH; Makin GS; Hopkinson BR
    Br J Surg; 1990 Feb; 77(2):179-82. PubMed ID: 2107957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator.
    Curl GR; Jakubowski JA; Deykin D; Bush HL
    Circulation; 1986 Sep; 74(3 Pt 2):I21-4. PubMed ID: 3091289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA).
    Buckenham TM; George CD; Chester JF; Taylor RS; Dormandy JA
    Eur J Vasc Surg; 1992 May; 6(3):237-40. PubMed ID: 1592125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.